D

DURECT Corp

DRRX

1.53000
USD
-0.11
(-6.71%)
Market Closed
Volume
739
EPS
0
Div Yield
0
P/E
-2
Market Cap
43,455,133
Related Instruments
AZN
2.040
(2.58%)
81.200 USD
C
CRBP
-0.500
(-0.84%)
59.160 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
MRNA
-25.020
(-20.99%)
94.160 USD
M
MX
0.67000
(13.16%)
5.76000 USD
PFE
0.115
(0.38%)
30.650 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: DURECT Corp

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derivedfrom the Europe .